These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1929286)

  • 1. Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in rats.
    Longuet P; Joly V; Amirault P; Seta N; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1303-8. PubMed ID: 1929286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
    Joly V; Dromer F; Barge J; Yeni P; Seta N; Molas G; Carbon C
    J Pharmacol Exp Ther; 1989 Oct; 251(1):311-6. PubMed ID: 2795463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary culture.
    Joly V; Saint-Julien L; Carbon C; Yeni P
    J Pharmacol Exp Ther; 1990 Oct; 255(1):17-22. PubMed ID: 2213553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Must we really fear toxicity of conventional amphotericin B in oncological patients?
    Mayer J; Doubek M; Vorlìcek J
    Support Care Cancer; 1999 Jan; 7(1):51-5. PubMed ID: 9926976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations.
    Joly V; Bolard J; Saint-Julien L; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1992 Feb; 36(2):262-6. PubMed ID: 1605590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid.
    Joly V; Farinotti R; Saint-Julien L; Chéron M; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1994 Feb; 38(2):177-83. PubMed ID: 8192439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of nephrotoxicity by a novel lipid nanosphere (NS-718) incorporating amphotericin B.
    Hossain MA; Maesaki S; Razzaque MS; Tomono K; Taguchi T; Kohno S
    J Antimicrob Chemother; 2000 Aug; 46(2):263-8. PubMed ID: 10933650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome) in beagle dogs.
    Bekersky I; Boswell GW; Hiles R; Fielding RM; Buell D; Walsh TJ
    Pharm Res; 1999 Nov; 16(11):1694-701. PubMed ID: 10571274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats.
    Wasan KM; Vadiei K; Lopez-Berestein G; Luke DR
    J Infect Dis; 1990 Mar; 161(3):562-6. PubMed ID: 2313133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subchronic toxicity studies of N-D-ornithyl amphotericin B methyl ester in dogs and rats.
    Massa T; Sinha DP; Frantz JD; Filipek ME; Weglein RC; Steinberg SA; McGrath JT; Murphy BF; Szot RJ; Black HE
    Fundam Appl Toxicol; 1985 Aug; 5(4):737-53. PubMed ID: 4043596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis.
    Wasan KM; Conklin JS
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1806-10. PubMed ID: 8843285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):828-33. PubMed ID: 11850268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice.
    Gondal JA; Swartz RP; Rahman A
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1544-8. PubMed ID: 2684010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats.
    Risovic V; Boyd M; Choo E; Wasan KM
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3339-42. PubMed ID: 14506053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium depletion potentiates amphotericin-B-induced toxicity to renal tubules.
    Bernardo JF; Murakami S; Branch RA; Sabra R
    Nephron; 1995; 70(2):235-41. PubMed ID: 7566310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic effects of flucytosine on amphotericin B nephrotoxicity in rats.
    Heidemann HT; Brune KH; Sabra R; Branch RA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2670-5. PubMed ID: 1482135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting cholesterol synthesis reduces the binding and toxicity of amphotericin B against rabbit renal tubular cells in primary culture.
    Joly V; Saint-Pierre-Chazalet M; Saint-Julien L; Bolard J; Carbon C; Yeni P
    J Infect Dis; 1992 Feb; 165(2):337-43. PubMed ID: 1730901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels.
    Arning M; Kliche KO; Heer-Sonderhoff AH; Wehmeier A
    Mycoses; 1995; 38(11-12):459-65. PubMed ID: 8720196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.